Síndrome mielodisplásica e resposta ao tratamento homeopático: relato de caso
Pacheco, Lucas Franco.
Rev. homeopatia (Säo Paulo)
; 81(3/4): 16-24, 2018. tab, ilus
Artigo em Espanhol | LILACS, HomeoIndex (homeopatia) | ID: biblio-969657
Documentos relacionados
[Management of patients with higher-risk myelodysplastic syndromes].
The effect of decitabine-combined minimally myelosuppressive regimen bridged allo-HSCT on the outcomes of pediatric MDS from 10 years' experience of a single center.
Novel therapies in myelodysplastic syndromes.
[Treatment of higher risk myelodysplastic syndromes].
Clinical decision-making and treatment of myelodysplastic syndromes.
Modeling hemoglobin levels of patients chronically transfused with red blood cells.
Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim.
MYELODYSPLASTIC SYNDROME: DIAGNOSIS, TREATMENT AND PROGNOSIS (LITERATURE REVIEW).
Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study.